[1]
BEDROSSIAN RH, CARMICHAEL P, RITTER J. Retinopathy of prematurity (retrolental fibroplasia) and oxygen. I. Clinical study. II. Further observations on the disease. American journal of ophthalmology. 1954 Jan:37(1):78-86
[PubMed PMID: 13114325]
[2]
Hardy RJ, Good WV, Dobson V, Palmer EA, Phelps DL, Quintos M, Tung B, Early Treatment for Retinopathy of Prematurity Cooperative Group. Multicenter trial of early treatment for retinopathy of prematurity: study design. Controlled clinical trials. 2004 Jun:25(3):311-25
[PubMed PMID: 15157731]
Level 1 (high-level) evidence
[3]
Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatric research. 2013 Dec:74 Suppl 1(Suppl 1):35-49. doi: 10.1038/pr.2013.205. Epub
[PubMed PMID: 24366462]
[4]
Essex RW, Carden SM, Elder JE. Two-year results of laser treatment for retinopathy of prematurity at a single neonatal intensive care unit. Clinical & experimental ophthalmology. 2005 Aug:33(4):390-4
[PubMed PMID: 16033352]
[5]
Broxterman EC, Hug DA. Retinopathy of Prematurity: A Review of Current Screening Guidelines and Treatment Options. Missouri medicine. 2016 May-Jun:113(3):187-90
[PubMed PMID: 27443043]
[6]
Dogra MR, Katoch D, Dogra M. An Update on Retinopathy of Prematurity (ROP). Indian journal of pediatrics. 2017 Dec:84(12):930-936. doi: 10.1007/s12098-017-2404-3. Epub 2017 Jul 4
[PubMed PMID: 28674824]
[7]
Flynn JT, Bancalari E, Snyder ES, Goldberg RN, Feuer W, Cassady J, Schiffman J, Feldman HI, Bachynski B, Buckley E. A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. The New England journal of medicine. 1992 Apr 16:326(16):1050-4
[PubMed PMID: 1549150]
[8]
Flynn JT, Chan-Ling T. Retinopathy of prematurity: two distinct mechanisms that underlie zone 1 and zone 2 disease. American journal of ophthalmology. 2006 Jul:142(1):46-59
[PubMed PMID: 16815250]
[9]
Schaffer DB, Palmer EA, Plotsky DF, Metz HS, Flynn JT, Tung B, Hardy RJ. Prognostic factors in the natural course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology. 1993 Feb:100(2):230-7
[PubMed PMID: 8437832]
[10]
Pastro J, Toso BRGO. Influence of oxygen in the development of retinopathy of prematurity. Revista brasileira de enfermagem. 2019 Jun 27:72(3):592-599. doi: 10.1590/0034-7167-2018-0361. Epub 2019 Jun 27
[PubMed PMID: 31269121]
[11]
Zhu Z, Hua X, Yu Y, Zhu P, Hong K, Ke Y. Effect of red blood cell transfusion on the development of retinopathy of prematurity: A systematic review and meta-analysis. PloS one. 2020:15(6):e0234266. doi: 10.1371/journal.pone.0234266. Epub 2020 Jun 8
[PubMed PMID: 32512582]
Level 1 (high-level) evidence
[12]
Kim SJ, Port AD, Swan R, Campbell JP, Chan RVP, Chiang MF. Retinopathy of prematurity: a review of risk factors and their clinical significance. Survey of ophthalmology. 2018 Sep-Oct:63(5):618-637. doi: 10.1016/j.survophthal.2018.04.002. Epub 2018 Apr 19
[PubMed PMID: 29679617]
Level 3 (low-level) evidence
[13]
Hård AL, Smith LE, Hellström A. Nutrition, insulin-like growth factor-1 and retinopathy of prematurity. Seminars in fetal & neonatal medicine. 2013 Jun:18(3):136-142. doi: 10.1016/j.siny.2013.01.006. Epub 2013 Feb 18
[PubMed PMID: 23428885]
[14]
Fierson WM, AMERICAN ACADEMY OF PEDIATRICS Section on Ophthalmology, AMERICAN ACADEMY OF OPHTHALMOLOGY, AMERICAN ASSOCIATION FOR PEDIATRIC OPHTHALMOLOGY AND STRABISMUS, AMERICAN ASSOCIATION OF CERTIFIED ORTHOPTISTS. Screening Examination of Premature Infants for Retinopathy of Prematurity. Pediatrics. 2018 Dec:142(6):. pii: e20183061. doi: 10.1542/peds.2018-3061. Epub
[PubMed PMID: 30478242]
[15]
Dunbar JA, Hsu V, Christensen M, Black B, Williams P, Beauchamp G. Cost-utility analysis of screening and laser treatment of retinopathy of prematurity. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2009 Apr:13(2):186-90. doi: 10.1016/j.jaapos.2008.10.014. Epub
[PubMed PMID: 19393519]
[16]
Binenbaum G, Tomlinson LA, de Alba Campomanes AG, Bell EF, Donohue P, Morrison D, Quinn GE, Repka MX, Rogers D, Yang MB, Yu Y, Ying GS, Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study Group. Validation of the Postnatal Growth and Retinopathy of Prematurity Screening Criteria. JAMA ophthalmology. 2020 Jan 1:138(1):31-37. doi: 10.1001/jamaophthalmol.2019.4517. Epub
[PubMed PMID: 31725856]
Level 1 (high-level) evidence
[17]
Ying GS. A Prediction Model for Retinopathy of Prematurity-Is It Ready for Prime Time? JAMA ophthalmology. 2020 Jan 1:138(1):29-30. doi: 10.1001/jamaophthalmol.2019.4608. Epub
[PubMed PMID: 31697322]
[18]
Quinn GE. The 'ideal' management of retinopathy of prematurity. Eye (London, England). 2005 Oct:19(10):1044-9
[PubMed PMID: 16304583]
[19]
Agarwal K, Jalali S. Classification of retinopathy of prematurity: from then till now. Community eye health. 2018:31(101):S4-S7
[PubMed PMID: 30275659]
[20]
Mintz-Hittner HA, Kuffel RR Jr. Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina (Philadelphia, Pa.). 2008 Jun:28(6):831-8. doi: 10.1097/IAE.0b013e318177f934. Epub
[PubMed PMID: 18536599]
[21]
Hu J, Blair MP, Shapiro MJ, Lichtenstein SJ, Galasso JM, Kapur R. Reactivation of retinopathy of prematurity after bevacizumab injection. Archives of ophthalmology (Chicago, Ill. : 1960). 2012 Aug:130(8):1000-6
[PubMed PMID: 22491394]
[22]
Snyder LL, Garcia-Gonzalez JM, Shapiro MJ, Blair MP. Very Late Reactivation of Retinopathy of Prematurity After Monotherapy With Intravitreal Bevacizumab. Ophthalmic surgery, lasers & imaging retina. 2016 Mar:47(3):280-3. doi: 10.3928/23258160-20160229-12. Epub
[PubMed PMID: 26985803]
[23]
Natarajan G, Shankaran S, Nolen TL, Sridhar A, Kennedy KA, Hintz SR, Phelps DL, DeMauro SB, Carlo WA, Gantz MG, Das A, Greenberg RG, Younge NE, Bliss JM, Seabrook R, Sánchez PJ, Wyckoff MH, Bell EF, Vohr BR, Higgins RD. Neurodevelopmental Outcomes of Preterm Infants With Retinopathy of Prematurity by Treatment. Pediatrics. 2019 Aug:144(2):. doi: 10.1542/peds.2018-3537. Epub 2019 Jul 23
[PubMed PMID: 31337693]
[24]
Quinn GE, Dobson V, Barr CC, Davis BR, Flynn JT, Palmer EA, Robertson J, Trese MT. Visual acuity in infants after vitrectomy for severe retinopathy of prematurity. Ophthalmology. 1991 Jan:98(1):5-13
[PubMed PMID: 2023732]
[25]
Seaber JH, Machemer R, Eliott D, Buckley EG, deJuan E, Martin DF. Long-term visual results of children after initially successful vitrectomy for stage V retinopathy of prematurity. Ophthalmology. 1995 Feb:102(2):199-204
[PubMed PMID: 7862407]
[26]
Trese MT, Droste PJ. Long-term postoperative results of a consecutive series of stages 4 and 5 retinopathy of prematurity. Ophthalmology. 1998 Jun:105(6):992-7
[PubMed PMID: 9627647]
[27]
Shah PK, Narendran V, Kalpana N, Tawansy KA. Anatomical and visual outcome of stages 4 and 5 retinopathy of prematurity. Eye (London, England). 2009 Jan:23(1):176-80
[PubMed PMID: 17676022]
[28]
Singh R, Reddy DM, Barkmeier AJ, Holz ER, Ram R, Carvounis PE. Long-term visual outcomes following lens-sparing vitrectomy for retinopathy of prematurity. The British journal of ophthalmology. 2012 Nov:96(11):1395-8. doi: 10.1136/bjophthalmol-2011-301353. Epub 2012 Aug 24
[PubMed PMID: 22923456]
[29]
Sen P, Jain S, Bhende P. Stage 5 retinopathy of prematurity: An update. Taiwan journal of ophthalmology. 2018 Oct-Dec:8(4):205-215. doi: 10.4103/tjo.tjo_61_18. Epub
[PubMed PMID: 30637192]
[30]
Good WV, Early Treatment for Retinopathy of Prematurity Cooperative Group. The Early Treatment for Retinopathy Of Prematurity Study: structural findings at age 2 years. The British journal of ophthalmology. 2006 Nov:90(11):1378-82
[PubMed PMID: 16914473]
[31]
Early Treatment for Retinopathy of Prematurity Cooperative Group, Good WV, Hardy RJ, Dobson V, Palmer EA, Phelps DL, Tung B, Redford M. Final visual acuity results in the early treatment for retinopathy of prematurity study. Archives of ophthalmology (Chicago, Ill. : 1960). 2010 Jun:128(6):663-71. doi: 10.1001/archophthalmol.2010.72. Epub 2010 Apr 12
[PubMed PMID: 20385926]
[32]
Msall ME, Phelps DL, Hardy RJ, Dobson V, Quinn GE, Summers CG, Tremont MR, Cryotherapy for Retinopathy of Prematurity Cooperative Group. Educational and social competencies at 8 years in children with threshold retinopathy of prematurity in the CRYO-ROP multicenter study. Pediatrics. 2004 Apr:113(4):790-9
[PubMed PMID: 15060229]
Level 2 (mid-level) evidence
[33]
Görbe E, Vámos R, Joó GJ, Jeager J, Molvarec A, Berecz B, Horváth A, Sulya B, Rigó J Jr. Perioperative analgesia of infants during the therapy for retinopathy of prematurity. Medical science monitor : international medical journal of experimental and clinical research. 2010 Apr:16(4):CR186-189
[PubMed PMID: 20357717]
[34]
Holmes JM, Kraker RT, Beck RW, Birch EE, Cotter SA, Everett DF, Hertle RW, Quinn GE, Repka MX, Scheiman MM, Wallace DK, Pediatric Eye Disease Investigator Group. A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology. 2003 Nov:110(11):2075-87
[PubMed PMID: 14597512]
Level 1 (high-level) evidence
[35]
Pediatric Eye Disease Investigator Group. The course of moderate amblyopia treated with patching in children: experience of the amblyopia treatment study. American journal of ophthalmology. 2003 Oct:136(4):620-9
[PubMed PMID: 14516801]
[36]
Tin W, Milligan DW, Pennefather P, Hey E. Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Archives of disease in childhood. Fetal and neonatal edition. 2001 Mar:84(2):F106-10
[PubMed PMID: 11207226]
[37]
Askie LM, Brocklehurst P, Darlow BA, Finer N, Schmidt B, Tarnow-Mordi W, NeOProM Collaborative Group. NeOProM: Neonatal Oxygenation Prospective Meta-analysis Collaboration study protocol. BMC pediatrics. 2011 Jan 17:11():6. doi: 10.1186/1471-2431-11-6. Epub 2011 Jan 17
[PubMed PMID: 21235822]
Level 1 (high-level) evidence
[38]
Darlow BA, Husain S. Primary prevention of ROP and the oxygen saturation targeting trials. Seminars in perinatology. 2019 Oct:43(6):333-340. doi: 10.1053/j.semperi.2019.05.004. Epub 2019 May 10
[PubMed PMID: 31151776]
[39]
Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. The Cochrane database of systematic reviews. 2017 Mar 21:3(3):CD004454. doi: 10.1002/14651858.CD004454.pub3. Epub 2017 Mar 21
[PubMed PMID: 28321847]
Level 1 (high-level) evidence
[40]
Rohwer AC, Oladapo OT, Hofmeyr GJ. Strategies for optimising antenatal corticosteroid administration for women with anticipated preterm birth. The Cochrane database of systematic reviews. 2020 May 26:5(5):CD013633. doi: 10.1002/14651858.CD013633. Epub 2020 May 26
[PubMed PMID: 32452555]
Level 1 (high-level) evidence
[41]
Lundgren P, Hellgren G, Pivodic A, Sävman K, Smith LEH, Hellström A. Erythropoietin serum levels, versus anaemia as risk factors for severe retinopathy of prematurity. Pediatric research. 2019 Aug:86(2):276-282. doi: 10.1038/s41390-018-0186-6. Epub 2018 Sep 18
[PubMed PMID: 30297879]
[42]
Lyu Y, Shah PS, Ye XY, Warre R, Piedboeuf B, Deshpandey A, Dunn M, Lee SK, Canadian Neonatal Network. Association between admission temperature and mortality and major morbidity in preterm infants born at fewer than 33 weeks' gestation. JAMA pediatrics. 2015 Apr:169(4):e150277. doi: 10.1001/jamapediatrics.2015.0277. Epub 2015 Apr 6
[PubMed PMID: 25844990]